Biotech Integrated Solutions From Pall's Process Engineering & Project Management Team
Source: Pall Corporation
Scaling gene therapy, mAb, or vaccine therapeutic drug products from bench to manufacturing involves a balancing act between project management, risk mitigation, and process parameter selection. A holistically-executed development that takes these into consideration can help identify and mitigate risks before they occur and protect the project budget – ultimately accelerating speed to market.
Join Pall for this webinar as they explore the ways to apply best practices through implementation of the Biotech Integrated Solutions service architecture for large-scale manufacturing projects, ultimately accelerating speed to market.
VIEW THE WEBINAR!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Drug Discovery Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Pall Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more